在接受立体定向体部放疗的胰腺癌患者中改进对当前分期指南预测手术可切除性的方法
本研究纳入2010至2016年接受立体定向体部放疗的191例交界可切除或局部晚期胰腺癌患者,构建分类回归树模型预测切缘阴性切除。模型预测准确性优于美国国家综合癌症网络指南分期(75% vs 63%;P < .05),并显示辐射剂量与可切除性相关。
要点
- 模型预测切缘阴性切除准确性75% vs 美国国家综合癌症网络指南分期63%(P < .05)。
- 预测因子包括化疗方案、动脉受累程度和年龄。
- 辐射剂量(GTV D95)在某些亚群中是可切除性的关键预测因子。
核心结论
- 研究证明模型对手术可切除性的预测可超越当前分期指南,突显以连续方式评估血管受累的价值。
- 研究显示辐射剂量与可切除性相关,提示辐射对某些人群允许切除的潜在重要性。
- 需要外部数据验证并提高模型的稳健性。
研究设计与样本
- 纳入2010至2016年接受立体定向体部放疗的局部晚期或交界可切除胰腺癌患者191例(局部晚期128例,交界可切除63例)。
- 主要终点为切缘阴性切除,预测因子包括年龄、性别、种族、治疗年份、体能状态、初始分期、肿瘤体积和位置、基线和立体定向体部放疗前糖类抗原19-9水平、化疗方案和持续时间及辐射剂量。
- 利用计算机断层扫描数据得出的重叠体积直方图描述肿瘤与关键动脉(肠系膜上动脉、腹腔干和肝总动脉)的关系。
- 构建分类回归树,并进行留一交叉验证。
- 使用McNemar检验比较模型与美国国家综合癌症网络指南分期对手术切除的预测。
主要发现
- 191例患者中87例(46%)接受切缘阴性切除。
- 中位总剂量为33 Gy。
- 预测因子包括化疗方案、动脉受累程度和年龄;覆盖95%大体肿瘤体积的辐射剂量(GTV D95)在某些亚群中是可切除性的关键预测因子。
- 模型预测切缘阴性切除的准确性为75%,美国国家综合癌症网络指南分期为63%(P < .05)。
关键数值与推荐
- 模型预测切缘阴性切除准确性75% vs 美国国家综合癌症网络指南分期63%(P < .05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要外部数据验证并提高模型的稳健性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: For patients with localized pancreatic cancer (PC) with vascular involvement, prediction of resectability is critical to define optimal treatment. However, the current definitions of borderline resectable (BR) and locally advanced (LA) disease leave considerable heterogeneity in outcomes within these classifications. Moreover, factors beyond vascular involvement likely affect the ability to undergo resection. Herein, we share our experience developing a model that incorporates detailed radiologic, patient, and treatment factors to predict surgical resectability in patients with BR and LA PC who undergo stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: Patients with BR or LA PC who were treated with SBRT between 2010 and 2016 were included. The primary endpoint was margin negative resection, and predictors included age, sex, race, treatment year, performance status, initial staging, tumor volume and location, baseline and pre-SBRT carbohydrate antigen 19-9 levels, chemotherapy regimen and duration, and radiation dose. In addition, we characterized the relationship between tumors and key arteries (superior mesenteric, celiac, and common hepatic arteries), using overlap volume histograms derived from computed tomography data. A classification and regression tree was built, and leave-one-out cross-validation was performed. Prediction of surgical resection was compared between our model and staging in accordance with the National Comprehensive Care Network guidelines using McNemar's test. RESULTS: A total of 191 patients were identified (128 patients with LA and 63 with BR), of which 87 patients (46%) underwent margin negative resection. The median total dose was 33 Gy. Predictors included the chemotherapy regimen, amount of arterial involvement, and age. Importantly, radiation dose that covers 95% of gross tumor volume (GTV D95), was a key predictor of resectability in certain subpopulations, and the model showed improved accuracy in the prediction of margin negative resection compared with National Comprehensive Care Network guideline staging (75% vs 63%; P < .05). CONCLUSIONS: We demonstrate the ability to improve prediction of surgical resectabiliy beyond the current staging guidelines, which highlights the value of assessing vascular involvement in a continuous manner. In addition, we show an association between radiation dose and resectability, which suggests the potential importance of radiation to allow for resection in certain populations. External data are needed for validation and to increase the robustness of the model.
引用
- Cheng Z, Rosati LM, Chen L, et al. Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy. Adv Radiat Oncol. 2018. PMID: 30370361. doi:10.1016/j.adro.2018.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。